Azenta, Inc.

NASDAQ:AZTA

Medical - Instruments & Supplies

Healthcare
$48.69 -0.11%

-$0.03 today

Market cap
$2.13B
Beta
1.40
P/E (TTM)
-5.9
EPS (TTM)
-$3.87
52W Low $15.93High $41.73

Volume 0.69M

Average 1.16M

AZTA Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Azenta, Inc.NASDAQ: AZTA

Gross Margin · Q4 FY2026 · quarter ended Sep 2026

Gross margin widens to 46.0%

Gross margin was 46.0% in Q4 FY2026, up 0.6 pp from a year earlier. On a trailing-twelve-month basis it was 44.2%, down 2.0 pp year over year. Over 3 fiscal years it widened by 9.2 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
46.0%+1.1 pp QoQ
Last fiscal yearSep 2026
44.2%-1.3 pp YoY
LTMSep 2026
44.2%-2.0 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.6 pp——
1 year-1.3 pp——
3 years+9.2 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2026
44.2%
Year-over-year change
-1.3pp

Gross Margin vs competitors

How AZTA compares with its peers on the latest reported figures

  • AZTA's LTM Sep 2026 gross margin of 44.2% is the 9th highest of the 10 companies compared; the peer median is 54.7%.
  • Its year-over-year change of -2.0 pp is the 8th highest of 10, against a peer median of +0.2 pp.
  • Over three fiscal years its change of +9.2 pp compares with a peer median of -2.0 pp.
AZTA Competitors Peer median
Gross Margin for AZTA and competitors
Company Period LTM level YoY 3-year change
TECHBio-Techne CorporationLTM Sep 202665.8% +0.4 pp-2.0 pp
BLFSBioLife Solutions, Inc.LTM Mar 202663.9% -19.5 pp+3.0 pp
MLABMesa Laboratories, Inc.LTM Mar 202663.5% +0.9 pp+2.5 pp
DHRDanaher CorporationLTM Sep 202658.6% -2.7 pp+0.2 pp
SOLVSolventum CorporationLTM Jun 202654.7% +0.2 pp-4.3 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 202651.9% -0.9 pp-3.9 pp
NEOGNeogen CorporationLTM Aug 202647.4% +6.3 pp-2.4 pp
BRKRBruker CorporationLTM Jun 202646.7% -1.6 pp-5.7 pp
AZTAAzenta, Inc.LTM Sep 202644.2% -2.0 pp+9.2 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202641.4% +1.0 pp-1.4 pp
Peer median (excluding AZTA) 54.7%+0.2 pp-2.0 pp

Competitors are the stored peer set for AZTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
FY2026
Sep 2026
Revenue555.5M665.07M573.45M593.82M621.7M
Cost of Revenue324.88M431.82M318.83M323.54M346.74M
Gross Profit230.62M233.26M254.62M270.28M274.96M
Gross Margin41.5%35.1%44.4%45.5%44.2%
Research & Development27.54M33.96M31.52M30.39M37.92M
Selling, General & Admin227.1M281.5M253.08M251.16M257.53M
Operating Expenses254.64M315.45M284.6M281.55M449.66M
Depreciation & Amortization53.7M85.58M90.74M61.21M0
EBITDA48.36M55.15M71.62M54.07M(151.01M)
EBITDA Margin8.7%8.3%12.5%9.1%-24.3%
Operating Income(24.02M)(82.2M)(29.98M)(11.27M)(174.7M)
Operating Margin-4.3%-12.4%-5.2%-1.9%-28.1%
Interest Income20.29M43.74M33.18M18.78M17.83M
Interest Expense4.59M0000
Other Income / Expenses14.09M51.77M10.86M4.13M23.69M
Income Before Tax(9.94M)(30.43M)(19.13M)(7.14M)(151.01M)
Pre-Tax Margin-1.8%-4.6%-3.3%-1.2%-24.3%
Income Tax Expense1.35M(17.55M)5.24M(31.6M)6.86M
Net Income(428.96M)(14.26M)(164.9M)(55.76M)(166.99M)
Net Margin-77.2%-2.1%-28.8%-9.4%-26.9%
EPS (Basic)(0.15)(0.22)(3.09)(1.22)(3.70)
EPS (Diluted)(0.15)(0.22)(3.09)(1.22)(3.70)
Weighted Avg Shares74.9M66.25M53.18M45.74M45.13M
Weighted Avg Shares (Diluted)74.9M66.25M53.18M45.9M45.13M

Azenta, Inc.

NASDAQ:AZTA

Intrinsic Alpha fair value

Locked

Current Price

$48.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.